Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The peptide calculator simplifies dosing calculations for both individual and combination protocols
The Kennedy Legacy: Jack, Bobby and Ted and a Family Dream Fulfilled
Tschop recounted his research with DiMarchi and that of others while he accepted the 2023 Banting Medal for Scientific Achievement at the 2023 American Diabetes Association Scientific Sessions.5 The FDA approved the first GLP-1 agonist, twice-a-day Byetta (exenatide), in 2005.1 Since then, several newer and more powerful medications in the GLP-1 agonist class, such as liraglutide and semaglutide, have received FDA approval for type 2 diabetes, with a higher dose of semaglutide FDA approved for weight loss.2 In mid-2022, the first dual agonist, tirzepetide (a combination of a GLP-1 agonist and a GIP), was FDA approved for type 2 diabetes
This is the core reason researchers interested in multi-axis tissue response sometimes examine both peptides in the same experimental design
GLP-1 (Tirzepatide / Semaglutide) Dose to Units Calculator Estimate your dose, syringe units, and mL precisely
